105 related articles for article (PubMed ID: 3339366)
41. Distribution of [3H]quinuclidinyl benzilate, [3H]nicotine, and [125I]alpha-bungarotoxin binding sites in the nucleus tractus solitarii of the cat.
Maley BE; Seybold VS
J Comp Neurol; 1993 Jan; 327(2):194-204. PubMed ID: 8425941
[TBL] [Abstract][Full Text] [Related]
42. Binding differences between nicotine and alpha-bungarotoxin in the rat brain.
Nukina I; Ogawa N; Takayama H; Ota Z
Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):141-4. PubMed ID: 2858912
[TBL] [Abstract][Full Text] [Related]
43. The reducing agent dithiothreitol (DTT) does not abolish the inhibitory nicotinic response recorded from rat dorsolateral septal neurons.
Sorenson EM; Gallagher JP
Neurosci Lett; 1993 Apr; 152(1-2):137-40. PubMed ID: 8515866
[TBL] [Abstract][Full Text] [Related]
44. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain.
Miao H; Liu C; Bishop K; Gong ZH; Nordberg A; Zhang X
J Neurochem; 1998 Feb; 70(2):752-62. PubMed ID: 9453571
[TBL] [Abstract][Full Text] [Related]
45. Similarity between rat brain nicotinic alpha-bungarotoxin receptors and stably expressed alpha-bungarotoxin binding sites.
Quik M; Choremis J; Komourian J; Lukas RJ; Puchacz E
J Neurochem; 1996 Jul; 67(1):145-54. PubMed ID: 8666985
[TBL] [Abstract][Full Text] [Related]
46. Genetic analysis of nicotine-induced seizures and hippocampal nicotinic receptors in the mouse.
Miner LL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1986 Dec; 239(3):853-60. PubMed ID: 3795045
[TBL] [Abstract][Full Text] [Related]
47. 14 beta-(Bromoacetamido)morphine irreversibly labels mu opioid receptors in rat brain membranes.
Bidlack JM; Frey DK; Seyed-Mozaffari A; Archer S
Biochemistry; 1989 May; 28(10):4333-9. PubMed ID: 2548575
[TBL] [Abstract][Full Text] [Related]
48. Modulation of the nicotinic alpha-bungarotoxin site in chromaffin cells in culture by a factor(s) endogenous to neuronal tissue.
Quik M; Fournier S; Trifaró JM
Brain Res; 1986 Apr; 372(1):11-20. PubMed ID: 3708351
[TBL] [Abstract][Full Text] [Related]
49. alpha-bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations.
Rakhilin S; Drisdel RC; Sagher D; McGehee DS; Vallejo Y; Green WN
J Cell Biol; 1999 Jul; 146(1):203-18. PubMed ID: 10402471
[TBL] [Abstract][Full Text] [Related]
50. Postnatal development of cholinergic enzymes and receptors in mouse brain.
Fiedler EP; Marks MJ; Collins AC
J Neurochem; 1987 Sep; 49(3):983-90. PubMed ID: 3612135
[TBL] [Abstract][Full Text] [Related]
51. Aromatic trivalent arsenicals: covalent yet reversible reagents for the agonist binding site of nicotinic receptors.
Loring RH; Dou YM; Lane W; Jones GS; Stevenson KJ
Brain Res Mol Brain Res; 1992 Sep; 15(1-2):113-20. PubMed ID: 1331657
[TBL] [Abstract][Full Text] [Related]
52. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
Quik M; Geertsen S; Trifaró JM
Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
[TBL] [Abstract][Full Text] [Related]
53. Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion.
Collins AC; Luo Y; Selvaag S; Marks MJ
J Pharmacol Exp Ther; 1994 Oct; 271(1):125-33. PubMed ID: 7965705
[TBL] [Abstract][Full Text] [Related]
54. Nicotinic receptors in the brain of Drosophila melanogaster demonstrated by autoradiography with [125I]alpha-bungarotoxin.
Dudai Y; Amsterdam A
Brain Res; 1977 Jul; 130(3):551-5. PubMed ID: 407972
[No Abstract] [Full Text] [Related]
55. Purification of a nicotinic acetylcholine receptor from rat brain by affinity chromatography directed at the acetylcholine binding site.
Dwork AJ; Desmond JT
Brain Res; 1991 Jun; 552(1):119-23. PubMed ID: 1913171
[TBL] [Abstract][Full Text] [Related]
56. Classical genetic analysis of nicotine-induced seizures and nicotinic receptors.
Miner LL; Marks MJ; Collins AC
J Pharmacol Exp Ther; 1984 Dec; 231(3):545-54. PubMed ID: 6502513
[TBL] [Abstract][Full Text] [Related]
57. An autoradiographic analysis of alterations in nicotinic cholinergic receptors following 1 week of corticosterone supplementation.
Pauly JR; Collins AC
Neuroendocrinology; 1993; 57(2):262-71. PubMed ID: 8510802
[TBL] [Abstract][Full Text] [Related]
58. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
Wonnacott S; Jackman S; Swanson KL; Rapoport H; Albuquerque EX
J Pharmacol Exp Ther; 1991 Oct; 259(1):387-91. PubMed ID: 1920126
[TBL] [Abstract][Full Text] [Related]
59. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains.
Stevens KE; Freedman R; Collins AC; Hall M; Leonard S; Marks MJ; Rose GM
Neuropsychopharmacology; 1996 Aug; 15(2):152-62. PubMed ID: 8840351
[TBL] [Abstract][Full Text] [Related]
60. Sensitivity to the seizure-inducing effects of nicotine is associated with strain-specific variants of the alpha 5 and alpha 7 nicotinic receptor subunit genes.
Stitzel JA; Blanchette JM; Collins AC
J Pharmacol Exp Ther; 1998 Mar; 284(3):1104-11. PubMed ID: 9495872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
